PB
Pedro Beltran sold $3K of BBOT stock
Pedro Beltran, President and CEO of BridgeBio Oncology Therapeutics, Inc. (BBOT), sold 1,870 shares of BBOT stock worth $3K, per an SEC Form 4 filed Nov 20, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 18, 2026, 2 days before it was made public.
BBOT has moved +0.3% since the trade date, from $1.80 to $1.81 (Nov 20, 2026 close).
- Traded
- Nov 18, 2026
- Disclosed
- Nov 20, 2026
- Filing delay
- 2 days
- Price since
- +0.3%
- Role
- President and CEO
- Source
- SEC Form 4